Study to Evaluate the Effectiveness of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Adults 65 Years of Age and Older

Clinical trial NCT04137887 · TERMINATED

Trial details

NCT number: NCT04137887
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza (Healthy Volunteers)

Start date: 2019-11-04
Primary completion: 2020-05-31
Enrollment: 33096

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.